GlobeNewsWire
12 Nov 2025, 21:01 UTC · 44w ago
Verdict
Headline takes no side. We score IDXG +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 85% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Interpace Biosciences achieved income from continuing operations of $1.0 million in Q3 2025.
More positive than 92% of claims this week
The company reported record thyroid test volumes, revenue ($8.8 million), and cash collections for the quarter.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 85% of claims this week
Interpace has transitioned into a 'Thyroid-only' diagnostics testing company as of Q3 2025.
So whatStrategic narrowing of focus often reduces overhead and operational complexity, improving margins.
More positive than 77% of claims this week
Average revenue per test increased by 5% and days sales outstanding (DSO) decreased by 22%.
So whatImproved reimbursement and faster cash collection enhance liquidity and pricing power.
More positive than 63% of claims this week
The company utilized its cash position to make additional principal payments on long-term debt.
More positive than 50% of claims this week
Which stocks this story touches
More positive than 85% of ticker scores this week
The company reported record thyroid test volumes and revenue, achieved profitability in continuing operations, and strengthened its balance sheet.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
2h ago
+30.2%
Price agrees with the score
$6.51 vs $5.00 close before publication (Nov 12) · not market-adjusted
IDXG chart →
